Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases

Anti-PD-1 antibodies (Abs) are among the optimal adjuvant therapies for melanoma at high risk of recurrence, especially BRAF wild-type melanoma, but the anti-tumour effects of anti-PD-1 Abs in the adjuvant setting for acral melanoma have not been evaluated previously. The aim of this study was to an...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Taku Fujimura
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Medical Journals Sweden 2022-08-01
סדרה:	Acta Dermato-Venereologica
נושאים:	adjuvant therapy acral melanoma anti-PD1 Abs RFS
גישה מקוונת:	https://medicaljournalssweden.se/actadv/article/view/678
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!